Lai Wang was appointed Global Head of R&D at BeOne Medicines.
2 reports, 2 independent
Updated Aug 29
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Lai Wang was appointed Global Head of R&D at BeOne Medicines.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
BeOne Medicines (Switzerland)
company in Basel, Switzerland
Nothing else this week.
-
Lai Wang
researcher (ORCID 0000-0001-7262-0020)
Nothing else this week.
Coverage
Newest first; wire copies grouped- Business WireBeOne Medicines Announces Positive Topline Results for Sonrotoclax in Relapsed or Refractory Mantle Cell Lymphoma (MCL) Study met its primary endpoint of overall response rate (ORR), demonstrating cl
- Insider MonkeyBeOne Medicines Ltd. (ONC) Unveils Promising Breast Cancer Therapies at ASCO 2025 We recently published 11 Best Cancer Stocks to Buy Right Now. BeOne Medicines Ltd. stands seventh among the best canc